Who
Matthew B. Murphy
General Counsel
Company insider
Files Form 4 as: General Counsel, Nautilus Biotechnology.
In numbers
- Trades disclosed
- 12
- Buys
- 4
- Sells
- 0
- Bought
- $79K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 14 Jun 2021
- Last trade
- 2 Mar 2026
- Last filed
- 4 Mar 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Mar 2026filed 4 Mar 2026 | NAUT Nautilus Biotechnologyoption or derivative · Life-science tools | SEC FORM 4 Code A | —160,000 at $0.00 | filing |
| 2 Mar 2026filed 4 Mar 2026 | NAUT Nautilus Biotechnologyoption or derivative · Life-science tools | SEC FORM 4 Code A | —160,000 at $0.00 | filing |
| 4 Sep 2025filed 5 Sep 2025 | NAUT Nautilus BiotechnologyLife-science tools | SEC FORM 4 Bought | $13K20,000 at $0.64 | filing |
| 3 Mar 2025filed 4 Mar 2025 | NAUT Nautilus Biotechnologyoption or derivative · Life-science tools | SEC FORM 4 Code A | —160,000 at $0.00 | filing |
| 1 Mar 2024filed 5 Mar 2024 | NAUT Nautilus Biotechnologyoption or derivative · Life-science tools | SEC FORM 4 Code A | —160,000 at $0.00 | filing |
| 27 Feb 2023filed 1 Mar 2023 | NAUT Nautilus Biotechnologyoption or derivative · Life-science tools | SEC FORM 4 Code A | —160,000 at $0.00 | filing |
| 15 Aug 2022filed 16 Aug 2022 | NAUT Nautilus BiotechnologyLife-science tools | SEC FORM 4 Bought | $21K7,500 at $2.84 | filing |
| 12 Aug 2022filed 16 Aug 2022 | NAUT Nautilus BiotechnologyLife-science tools | SEC FORM 4 Bought | $7,1252,500 at $2.85 | filing |
| 12 May 2022filed 13 May 2022 | NAUT Nautilus BiotechnologyLife-science tools | SEC FORM 4 Code A | $33K10,000 at $3.28 | filing |
| 25 Feb 2022filed 25 Feb 2022 | NAUT Nautilus Biotechnologyoption or derivative · Life-science tools | SEC FORM 4 Code A | —140,000 at $0.00 | filing |
| 13 Aug 2021filed 13 Aug 2021 | NAUT Nautilus BiotechnologyLife-science tools | SEC FORM 4 Bought | $38K5,000 at $7.56 | filing |
| 14 Jun 2021filed 4 Aug 2021 | NAUT Nautilus Biotechnologyoption or derivative · Life-science tools | SEC FORM 4 Code A | —326,526 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.